Are trials in New World monkeys on the critical path for blood-stage malaria vaccine development?
- 1 September 2001
- journal article
- opinion
- Published by Elsevier in Trends in Parasitology
- Vol. 17 (9) , 415-419
- https://doi.org/10.1016/s1471-4922(01)02011-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC‐Pf7, a Pox‐Vectored, Multiantigen, Multistage Vaccine Candidate forPlasmodium falciparumMalariaThe Journal of Infectious Diseases, 1998
- Research toward vaccines against malariaNature Medicine, 1998
- Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudiVaccine, 1998
- Vaccines Against the Blood Stages of Falciparum MalariaPublished by Springer Nature ,1998
- A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalariaNew England Journal of Medicine, 1997
- Safety, Immunogenicity, and Efficacy of a Recombinantly Produced Plasmodium falciparum Circumsporozoite Protein-Hepatitis B Surface Antigen Subunit VaccineThe Journal of Infectious Diseases, 1995
- Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigenParasite Immunology, 1988
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINEThe Lancet, 1987
- Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium bergheiNature, 1967